0000899243-20-017886.txt : 20200630
0000899243-20-017886.hdr.sgml : 20200630
20200630064930
ACCESSION NUMBER: 0000899243-20-017886
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200630
DATE AS OF CHANGE: 20200630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GANNON STEVEN
CENTRAL INDEX KEY: 0001643085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39344
FILM NUMBER: 201000384
MAIL ADDRESS:
STREET 1: C/O XENON PHARMACEUTICALS INC.
STREET 2: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A0
ZIP: V5G 4W8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001805890
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
BUSINESS PHONE: 289-799-0891
MAIL ADDRESS:
STREET 1: 270 LONGWOOD ROAD SOUTH
CITY: HAMILTON
STATE: A6
ZIP: L8P 0A6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-25
0
0001805890
Fusion Pharmaceuticals Inc.
FUSN
0001643085
GANNON STEVEN
C/O FUSION PHARMACEUTICALS INC.
270 LONGWOOD ROAD SOUTH
HAMILTON
A6
L8P 0A6
ONTARIO, CANADA
1
0
0
0
Stock Option (Right to Buy)
2.35
2020-01-19
4
A
0
141011
0.00
A
2030-01-19
Non-Voting Common Shares
141011
141011
D
Stock Option (Right to Buy)
17.00
2020-06-25
4
A
0
30000
0.00
A
2030-06-18
Common Shares
30000
30000
D
This option shall vest and become exercisable in 36 equal monthly installments beginning on February 19, 2020. Prior to closing of the Issuer's initial public offering, such Non-Voting Common Shares will convert into Voting Common Shares and subsequently into Common Shares on a one-for-one basis.
This option shall vest and become exercisable in 36 equal monthly installments beginning on July 18, 2020.
/s/ John Crowley, Attorney-in-Fact
2020-06-29